NMRA - Neumora Corp Bozor kapitallashuvining daromadga nisbati
Neumora Therapeutics (NMRA) navacaprant sinovlarining yakuniy bosqichlariga e'tibor qaratmoqda va inqilobiy ma'lumotlarni kutmoqda. Markaziy nerv tizimi buzilishlari uchun maqsadli davolash vositalarini ishlab chiqish uzoq muddatli patent himoyasi va barqaror talabni ta'minlaydi. Daromad koeffitsiyenti tendentsiyasi bozor baholashini tasdiqlaydi, bunda qiymat miqdorida belgilangan. Bu depressiya va xavotir buzilishlarini individuallashtirilgan davolash uchun aniq neyrofan ekotizimini yaratishni qo'llab-quvvatlaydi.
Neumora Therapeutics (NMRA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Neumora Therapeutics|NMRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Neumora Therapeutics|NMRA - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Neumora Therapeutics|NMRA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Neumora Therapeutics|Shoshilinch likvidlik neumoratx.com
- foyda va bozor koeffitsiyentlari statistikasi:
NMRA - Sof daromad|Prognoz qilingan kelajakdagi foyda Neumora Therapeutics|NMRA - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Neumora Therapeutics Inc|NMRA - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Neumora Corp|NMRA - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Neumora Therapeutics|NMRA - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi neumoratx.com|NMRA - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Neumora Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:NMRA Neumora
Neumora Therapeutics (NMRA) og'ir psixiatrik va neyrodegenerativ kasalliklarni davolash uchun innovatsion dori vositalarini ishlab chiqishga e'tibor qaratadi, bunda biznes qiymati klinik sinovlarning muvaffaqiyatiga bog'liqdir. Sotuvlar nisbatini (price-to-sales ratio) tahlil qilish orqali investor sotuvlarning har bir dollari uchun bozor qiymatini aniqlaydi, bu esa joriy buxgalteriya natijalarini bozor kutuvlaridan ajratish hamda kompaniyaning kelajakdagi texnologik yutuqlari uchun haddan tashqari ko'p to'lov qilish xavfini baholash imkonini beradi.
Neumora Therapeutics raqobatchilari
BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Narxning sotuvga nisbati SCLX|Tevogen Bio Inc. (TVGN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati ACOG|CGTX (cogrx.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati inhibikase.com (IKT)|Narxning daromadga nisbati Cassava Sciences Inc (SAVA)|Narx/daromad koeffitsiyenti Assertio|P/S multiplikatori COYA (Coya Therapeutics, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalizatsiyaning daromadga nisbati|ABOS: Narxning daromadga nisbati|CervoMed (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen)|Kapitalizatsiyaning daromadga nisbati JUNS (Jupiter Neurosciences, Inc.)|P/S multiplikatori relmada.com (RLMD)|Narxning daromadga nisbati Annovis Bio Corp ANVS|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (anewmeds.com) - Kapitalizatsiya va daromad nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalizatsiyaning daromadga nisbati|revivapharma.com - Bozor kapitallashuvining daromadga nisbati|MTVA (metaviatx.com) - P/S multiplikatori|NRXS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati
